It’s a great idea to invest in us – and here’s why
- Poised for long-term growth; building on attractive mega trends in Life Science, Healthcare and Electronics
- Resilient and high-quality cashflow profile; reliable cash generation leveraging multi-industry set up
- Strong M&A track record enhanced by rapid deleveraging
- Bringing innovation faster to patients and customers, contributing to their sustainability efforts

Related News
View All News-
Press Releases
Launch of EdiMembre to Transform Alternative Protein Industry
Together with mantro GmbH we have established EdiMembre, Inc., Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry.
2025/08/18
-
Press Releases
European Commission Grants Approval of Ogsiveo
The European Commission granted approval for Ogsiveo for the treatment of adults with desmoid tumors.
2025/08/18
-
Press Releases
Q2 2025: Merck KGaA, Darmstadt, Germany, Delivers Profitable Organic Growth ...
Strong sales in Process Solutions and for blockbusters Mavenclad and Erbitux, sustained demand for Semiconductor Materials.
2025/08/07


Share Price
Check Share PriceShare Price

